Main focus of R&D 2023
Our research centres carry out all stages of innovative product development: from the discovery and synthesis of peptide molecules to the development of finished dosage forms and the implementation and testing of technologies in industrial production.
Our research areas and scientific interests in the development of innovative peptide-based products link us to leading laboratories and research centres around the world.
Below is a list of our key research areas that we are currently working on to expand our list of active pharmaceutical ingredients.
Our research areas and scientific interests in the development of innovative peptide-based products link us to leading laboratories and research centres around the world.
Below is a list of our key research areas that we are currently working on to expand our list of active pharmaceutical ingredients.
1
Study of a peptide compound PXe5. Normalization of the circadian rhythms during violation of lighting regime. The 6-COMT melatonin analysis test.
2
Study of a bronchoprotective action of peptide compound PXp3 in bronchoalveolitis and COPD animal models
3
The effect of peptide compounds PXn8 and PXn5 on the experimental dementia (Alzheimer's disease) and degenerative brain diseases (Parkinson's disease) (in vitro/in vivo)
4
Study of the pharmacokinetics of a PXn8 and PXn5 to ensure the following of guidelines for the FDA submission protocol
5
The study of regulation of the functional activity of photoreceptors and retinal pigment epithelium as a result of administration of compound PXv11.
Meet our team
Get acquainted and follow the journey of the people behind the development of this revolutionary technology
R&D sites
Our company boasts a mixture of in house research as well as cooperation with major world laborotries